Abbott Products: Clinical Trials

11 trials sponsored by Abbott Products, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 terminated. 4 Phase 2, 3 Phase 3, 2 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 2
Phase 33Completed 3
Phase 12Completed 1, Terminated 1
Phase 42Completed 2

Follow Abbott Products: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency
Pancreatin - Pancreatic Exocrine Insufficiency
Phase 3CompletedAbbott Products402012-06-012014-07-15
The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow
betahistine dihydrochloride, placebo - Gait or Balance Disorder Problems
Phase 4CompletedAbbott Products272012-02-012017-10-26
14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man
SLV337 suspension, SLV337 capsule - Healthy Subjects
Phase 1CompletedAbbott Products122010-07-012011-08-26
First in Man Study With SLV342
SLV342, placebo - Pharmacokinetics
Phase 1TerminatedAbbott Products482010-01-012011-08-25
A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes
Placebo, SLV337 - Type 2 Diabetes
Phase 2CompletedAbbott Products612009-12-012012-01-04
A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.
pardoprunox, pramipexole - Advanced Stage Parkinson's Disease
Phase 2TerminatedAbbott Products372009-09-012011-08-26
A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.
SLV334, Placebo - Traumatic Brain Injury
Phase 2TerminatedAbbott Products572009-04-012011-09-21
Effect of Choline Fenofibrate (SLV348) on Macular Edema
Choline Fenofibrate, Placebo - Diabetic Macular Edema
Phase 2CompletedAbbott Products1102008-09-012011-08-26
Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis
Pancreatin, Placebo - Pancreatic Insufficiency
Phase 3CompletedAbbott Products622008-06-012011-08-18
Creon After Pancreatic Surgery
Creon, Placebo - Pancreatic Insufficiency
Phase 4CompletedAbbott Products582008-04-012011-08-18
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
Dydrogesterone, Placebo - Recurrent Miscarriage
Phase 3CompletedAbbott Products712003-09-012011-08-26

Conditions studied

Exocrine Pancreatic Insufficiency (3)  ·  Abortion, Habitual (1)  ·  Atherosclerosis (1)  ·  Brain Injuries (1)  ·  Brain Injuries, Traumatic (1)  ·  Cystic Fibrosis (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Parkinson Disease (1)

Interventions

Pancreatin (2)  ·  Betahistine (1)  ·  Dydrogesterone (1)  ·  Pancrelipase (1)  ·  Pramipexole (1)  ·  pardoprunox (1)

Countries

Italy (4)  ·  Bulgaria (3)  ·  Germany (3)  ·  Poland (3)  ·  Hungary (2)  ·  Netherlands (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  India (1)  ·  Israel (1)  ·  Portugal (1)  ·  Russia (1)

Top investigators

Guenter Krause, MD (3)  ·  Anita Vanderlaan (1)  ·  Dmitri Kazei, MD (1)  ·  Dr Jean-Claude Ansquer, MD (1)  ·  Francis Roy, MS (1)  ·  Ingrid Meuwsen, MS (1)  ·  Juliana Bronzova, MD (1)  ·  Juliana Bronzowa, MD (1)  ·  Suntje Sander-Struckmeier, PhD (1)

Results publications

PMID 25066363

NIH funding

2008 (3), 2009 (2), 2005 (1)